Skip to main content

Trimedyne Reports Its Financial Results for the Quarter Ending on December 31, 2019

Written by Customer Service on . Posted in Public Companies.

Irvine, CA, Feb. 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — TRIMEDYNE, INC. (OTCPINK “TMED”) today reported its financial results for its quarter ending on December 31, 2019.
For the Quarter Ended December 31, 2019, Trimedyne had revenues of $868,000, a decrease of 27% from revenues of $1,188,000 for the prior year quarter.  As a result of this decrease, we had a net loss for the current quarter of $63,000 or $0.51 per share, as compared to a net loss of $31,000 or $0.25 per share for the prior year quarter. Cash and equivalents increased by $171,000 as compared to the prior year ended September 30, 2019, primarily due to the receipt of customer deposits for future orders.Commenting on the financial results for the quarter, Glenn D. Yeik., Interim Chairman of Trimedyne, said: “The quarter ended December 31, 2019 was a particularly challenging quarter, due to a reduction in sales in each of our segments, combined with difficulties in setting up a new laser manufacturing facility in Corona, California. However, during this quarter, we were able to successfully complete our Medical Device Single Audit Program (MDSAP) audits for our ISO 13485:2016 certification, and acted to improve our relationships with key international distributors.We have and continue to pursue options to improve the short-term and long-term prospects of the company.”To view Trimedyne’s financials, please click on the link below:TRIMEDYNE FINANCIAL STATEMENTS DECEMBER 31, 2019CONTACT: Jeffrey Rudner
(949) 951-3800
jrudner@trimedyne.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.